Rise Advisors »

Nektar Therapeutics shares owned by Rise Advisors

Quarter-by-quarter ownership of Nektar Therapeutics shares owned by Rise Advisors from 13F filings

Historical chart of Rise Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Rise Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9k 69 56.90
2025-06-30 $1.3k 49 25.84

More positions owned by Rise Advisors

Vanguard Growth Etf 0 (VUG)
Vanguard Value Etf 0 (VTV)
Vanguard Core Bond Etf 0 (VCRB)
Janus Henderson Mortgage-backed Securities Etf 0 (JMBS)
Fidelity Total Bond Etf 0 (FBND)
Janus Henderson Small/mid Cap Growth Alpha Etf 0 (JSMD)
Janus Henderson Short Duration Income Etf 0 (VNLA)
Ft Vest Laddered Moderate Buffer Etf 0 (BUFZ)
Financial Select Sector Spdr Fund 0 (XLF)
Industrial Select Sector Spdr Fund 0 (XLI)
Nvidia Corporation 0 (NVDA)
Microsoft Corp 0 (MSFT)
Apple 0 (AAPL)
Berkshire Hathaway Inc Del Cl B 0 (BRK.B)
Energy Select Sector Spdr Fund 0 (XLE)

View all positions for Rise Advisors

Top funds holding Nektar Therapeutics

49 Wealth Management
Parallel Advisors
EverSource Wealth Advisors
Rise Advisors
Fortitude Family Office
AllSquare Wealth Management
Nova Wealth Management
Huntington National Bank
LRI Investments

View all funds holding Nektar Therapeutics